Alexza
Navigation Links
Alexza in Medical News
MOUNTAIN VIEW, Calif., May 29 /PRNewswire-FirstCall/ -- Alexza
Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced today that Anthony Clarke,
PhD, has joined the company as Vice President, International Development
Operations. He will have primary responsibilities in the development and
execution...
...IN VIEW, Calif., July 27 /PRNewswire-FirstCall/ -- alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced ...ber for the replay of the call is 21321723. alexza Pharmaceuticals is a pharmaceutical company focuse...on in schizophrenic or bipolar disorder patients. alexza has completed and announced positive results from ...
...IN VIEW, Calif., June 15 /PRNewswire-FirstCall/ -- alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced ... purchase of Symphony Allegro, which is subject to alexza stockholder approval, is projected to close in Q3 2009. alexza and Symphony Capital Partners, LP have negotiated ...
...N VIEW, Calif., May 11 /PRNewswire-FirstCall/ -- alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced ... http://www.wsw.com/webcast/jmp8/alxa or at the alexza Investor Relations tab at www.alexza.com . ...e replay will be archived for 14 days. About alexza Pharmaceuticals, Inc. ...
...IN VIEW, Calif., March 9 /PRNewswire-FirstCall/ -- alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced ...e replay will be archived for 14 days. About alexza Pharmaceuticals, Inc. alexza Pharmaceuticals is an emerging specialty pharmaceu...
...IN VIEW, Calif., March 6 /PRNewswire-FirstCall/ -- alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced ...umber for the replay of the call is 94291130. alexza Pharmaceuticals is an emerging specialty pharmaceu...on in schizophrenic or bipolar disorder patients. alexza has completed and announced positive results from ...
Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd.
MOUNTAIN VIEW, Calif., May 19 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced today that Jeffrey S. Williams has rejoined the company in a part-time position as President, Alexza Singapore Pte. Ltd., a wholly owned subsidiary of Alexza. Mr. Williams will have ...Carlos A. Parra Joins Alexza Pharmaceuticals as Vice President, Quality
MOUNTAIN VIEW, Calif., May 15 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced today that Carlos A. Parra has joined the company as Vice President, Quality. He will have responsibilities in the development and execution of quality program strategies for Alexza'......IN VIEW, Calif., July 27 /PRNewswire-FirstCall/ -- alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced ...ber for the replay of the call is 21321723. alexza Pharmaceuticals is a pharmaceutical company focuse...on in schizophrenic or bipolar disorder patients. alexza has completed and announced positive results from ...
...IN VIEW, Calif., June 15 /PRNewswire-FirstCall/ -- alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced ... purchase of Symphony Allegro, which is subject to alexza stockholder approval, is projected to close in Q3 2009. alexza and Symphony Capital Partners, LP have negotiated ...
Alexza's Corporate Presentation to be Webcast at the Piper Jaffray Fourth Annual Europe Conference
...IN VIEW, Calif., June 11 /PRNewswire-FirstCall/ -- alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced ...zhtml?ticker=ALXA&item_id=2262656 or at the alexza Investor Relations tab at www.alexza.com . ...e replay will be archived for 14 days. About alexza Pharmaceuticals, Inc. ......N VIEW, Calif., May 11 /PRNewswire-FirstCall/ -- alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced ... http://www.wsw.com/webcast/jmp8/alxa or at the alexza Investor Relations tab at www.alexza.com . ...e replay will be archived for 14 days. About alexza Pharmaceuticals, Inc. ...
Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status
...N VIEW, Calif., March 10 /PRNewswire-FirstCall/ -- alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) reported t... $45.1 million in the comparable periods in 2007. alexza had consolidated cash, cash equivalents and market...n currently anticipated. On January 1, 2006, alexza adopted FAS 123R and reports employee share-based ......IN VIEW, Calif., March 9 /PRNewswire-FirstCall/ -- alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced ...e replay will be archived for 14 days. About alexza Pharmaceuticals, Inc. alexza Pharmaceuticals is an emerging specialty pharmaceu...
...IN VIEW, Calif., March 6 /PRNewswire-FirstCall/ -- alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced ...umber for the replay of the call is 94291130. alexza Pharmaceuticals is an emerging specialty pharmaceu...on in schizophrenic or bipolar disorder patients. alexza has completed and announced positive results from ...
Alexza in Medical Technology
Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration
CHADDS FORD, Pa., Jan. 29 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP ) announced today that by mutual agreement it has concluded its research collaboration with Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) to develop an inhaled fentanyl product for the treatment of breakthrou...Alexza Reports 2009 First Quarter Financial Results and Updates Clinical Pipeline Status
...TAIN VIEW, Calif., May 7 /PRNewswire-FirstCall/ -- alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) reported t...f $18.4 million in the comparable period in 2008. alexza had consolidated cash, cash equivalents and market...opment Update - AZ-004 ( Staccato loxapine). alexza is developing AZ-004 for the acute treatment of ag......, a product development partnership formed between alexza and Symphony Capital, LLC. The AZ-104 Phase...mptoms of migraine headache," said Thomas B. King, alexza President and CEO. "We believe the potential valu...at least two groups of potential patients for whom alexza believes that AZ-104 could be effective and safe i...
..., a product development partnership formed between alexza and Symphony Capital, LLC. "Alexza initiat...secondary endpoints," said James V. Cassella, PhD, alexza Senior Vice President, Research and Development. ... to acutely treat agitation," said Thomas B. King, alexza President and CEO. "We are very encouraged with t...
...secondary endpoints," said James V. Cassella, PhD, alexza Senior Vice President, Research and Development. "...te to treat acute agitation," said Thomas B. King, alexza President and CEO. "We are very encouraged with th...on in early 2010." Conference Call Information alexza will host a conference call later today, Tuesday, ...
Alexza Reports 2008 Second Quarter Financial Results and Updates Development of Product Candidates
...d $21.2 million in the comparable periods in 2007. alexza had consolidated cash, cash equivalents and market...re-based compensation costs. On January 1, 2006, alexza adopted FAS 123R and reports employee share-based ...evelopment Update -- AZ-004 (Staccato loxapine). alexza is developing AZ-004 for the treatment of acute ag...Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
..., a product development partnership formed between alexza and Symphony Capital, LLC. "We are excited to be...before the end of September," said Thomas B. King, alexza President and CEO. "This year is a transitional ye... AZ-004 study enrolling bipolar disorder patients. alexza projects that this second Phase 3 clinical trial w......patients with schizophrenia or bipolar disorder. alexza Pharmaceuticals is an emerging specialty pharmaceu...h greater ease, patient comfort and convenience. alexza has six product candidates in clinical development...ation, including this and past press releases from alexza is available online at http://www.alexza.com . ...
...n patients with schizophrenia or bipolar disorder. alexza believes the novel, non-invasive nature and rapid ...r original schedule," said James V. Cassella, PhD, alexza Senior Vice President, Research and Development an...tential sales and marketing," said Thomas B. King, alexza President and CEO. "We also remain on schedule to ...
...n patients with schizophrenia or bipolar disorder. alexza will host an investor conference call to discuss t...Senior Vice President, Research and Development at alexza and chairman of the Symphony Allegro Development B...tack. About Symphony Allegro In December 2006, alexza entered into a collaboration with Symphony Capital...
Alexza in Biological Technology
MOUNTAIN VIEW, Calif., July 9 /PRNewswire-FirstCall/ -- Alexza
Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced today that Christopher Kurtz
has joined the company as Vice President, Global Supply Chain and
Sustainment Engineering. He will have primary responsibilities in the
development and e...
...N VIEW, Calif., April 30 /PRNewswire-FirstCall/ -- alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced ...umber for the replay of the call is 16474219. alexza Pharmaceuticals is a pharmaceutical company focuse...on in schizophrenic or bipolar disorder patients. alexza has completed and announced positive results from ...
...N VIEW, Calif., March 23 /PRNewswire-FirstCall/ -- alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced ...e replay will be archived for 14 days. About alexza Pharmaceuticals, Inc. alexza Pharmaceuticals is an emerging specialty pharmaceu...
...3% of the Company's total workforce. In addition, alexza and Endo Pharmaceuticals, Inc. have agreed to mutu...additional resources to AZ-003 during 2009. alexza expects to reduce its expenses by approximately $2...ed to fiscal year 2009. As of September 30, 2008, alexza had $78.0 million in cash and investments. As a r...
... Anesiva, he was chief medical officer of Eleos, Inc., a private company. From 2005 to 2007 he was vice president, clinical and regulatory affairs for alexza Pharmaceuticals, Inc., where he was responsible for the development and conduct of clinical trials for a novel Fentanyl formulation, among others. Fro...
...allers. The reference number to enter the replay of the call is 47372481. alexza Pharmaceuticals is an emerging specialty pharmaceutical company focused on ...s administration, but with greater ease, patient comfort and convenience. alexza has six product candidates in clinical development. Alexza's lead program, ...
Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
MOUNTAIN VIEW, Calif., Feb. 27 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced today that Michael J. Simms has joined the company as Senior Vice President, Operations and Manufacturing. Mr. Simms was most recently Senior Vice President, Manufacturing Operation......N VIEW, Calif., April 30 /PRNewswire-FirstCall/ -- alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced ...umber for the replay of the call is 16474219. alexza Pharmaceuticals is a pharmaceutical company focuse...on in schizophrenic or bipolar disorder patients. alexza has completed and announced positive results from ...
...N VIEW, Calif., March 23 /PRNewswire-FirstCall/ -- alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced ...e replay will be archived for 14 days. About alexza Pharmaceuticals, Inc. alexza Pharmaceuticals is an emerging specialty pharmaceu...
Alexza's Corporate Presentation to be Webcast at the 11th Annual BIO CEO & Investor Conference
...replay will be archived for 14 days. About alexza Pharmaceuticals, Inc. alexza Pharmaceuticals is an emerging specialty pharmaceu...on in schizophrenic or bipolar disorder patients. alexza has completed and announced positive results from ......3% of the Company's total workforce. In addition, alexza and Endo Pharmaceuticals, Inc. have agreed to mutu...additional resources to AZ-003 during 2009. alexza expects to reduce its expenses by approximately $2...ed to fiscal year 2009. As of September 30, 2008, alexza had $78.0 million in cash and investments. As a r...
... Anesiva, he was chief medical officer of Eleos, Inc., a private company. From 2005 to 2007 he was vice president, clinical and regulatory affairs for alexza Pharmaceuticals, Inc., where he was responsible for the development and conduct of clinical trials for a novel Fentanyl formulation, among others. Fro...
Alexza Pharmaceuticals Announces Upcoming Webcasts and Conference Participation
...e company's participation and that Thomas B. King, alexza President and CEO, will present at the following i...accessed via the Investor Relations section of the alexza website, at http://www.alexza.com . A replay of t...d the replay will be archived for 14 days. About alexza Pharmaceuticals ......allers. The reference number to enter the replay of the call is 47372481. alexza Pharmaceuticals is an emerging specialty pharmaceutical company focused on ...s administration, but with greater ease, patient comfort and convenience. alexza has six product candidates in clinical development. Alexza's lead program, ...
Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates
...of $10.9 million in the comparable period in 2007. alexza had consolidated cash, cash equivalents and market...re-based compensation costs. On January 1, 2006, alexza adopted FAS 123R and reports employee share-based ...velopment Update -- AZ-004 (Staccato loxapine). alexza is developing AZ-004 for the treatment of acu...Other TagsplusplusplusplusplusdualdualdualdualdualdictatetheytheytheyOther Contentsfibrillationfibrillationfibrillationfibrillationfibroidfibroidfifthfifthfifthfifthfifthfinefinefinefinefinefinefinefinefirefirefirefirefirefirekitkitkitkitkitkitkitaidaidaidaidaidaidaidaidaid
(Date:12/1/2009)... , , SAN DIEGO, Dec. 1 /PRNewswire-Fi...ied supplier of Farming, Nursery and Wellness prod...ing agreement with Southern California Micro-Lendi...m ). ,, Yan Skwara, CEO of US Farms, Inc. stat... partnership with Angels in Action utilizing our A...
(Date:12/1/2009)... , , BRUSSELS, December 1 /PRNewswir...perts Agree That Adapting Food,Production and Mode...ons , Prof. John Beddington, Chief Scient...ll agricultural policy must be founded on science ...cientific advisor with the,responsibility to look ...
(Date:12/1/2009)... Some become so worried about what might happen t..., , TUESDAY, Dec. 1 (HealthDay News) -- ...into depression, a new study suggests. , "Anxie...udy author Andres Viana, a graduate student in psy...ose with anxiety sensitivity are afraid of their a...
(Date:12/1/2009)... Radiation exposures in younger women may up chan... Dec. 1 (HealthDay News) -- Mammograms may actuall...k women, a new study suggests. , Dutch research...r examining the effect of low-dose radiation expos...mutation boosting breast cancer risk and two looki...
(Date:12/1/2009)... , Research released in the December 2009 issue o...ermine whether the survival improvement among pati... the last two decades as reported in controlled cl...sis of over 100,000 patients with stage IV non-sma... SEER database to evaluate trends in survival betw...
Breaking Medicine News(10 mins):Health News:US Farms, Inc. Announces Marketing Agreement With Micro Lending Institution Angels In Action 2Health News:US Farms, Inc. Announces Marketing Agreement With Micro Lending Institution Angels In Action 3Health News:Food Security to be the Top Issue for EU's Science Chief 2Health News:Fear of Anxiety May Lead to Depression 2Health News:Mammograms May Boost Cancer Risk in High-Risk Women 2[0] US Farms, Inc. Announces Marketing Agreement With Micro Lending Institution Angels In Action[0] Food Security to be the Top Issue for EU's Science Chief[0] Fear of Anxiety May Lead to Depression[0] Mammograms May Boost Cancer Risk in High-Risk Women[0] Study shows modest improvement in advanced lung cancer overall survival rates
(Date:11/30/2009)... research report published in the December 2009 pr...e men similar type of control over their fertility...se scientists have found how and where androgenic ...m production and male fertility. This opens a prom... men. The discovery also offers hope to those who ...
(Date:11/30/2009)...on is a colorless and odorless radioactive gas tha...Radium is a product of uranium decay and is found ...ils, and groundwater as well as building materials...concentration is expressed as the amount of radiat...roducts in a liter of air; thus the units are pico...
(Date:11/26/2009)...d for their impressive antlers, red deer have been...t a deer,s antlers are much more than decorative. ...when duelling. John Currey, from The University of...operties of bone for over half a century and has b...ntler through a long-standing collaboration with T...
Breaking Biology News(10 mins):Health Physics Society recommends considering action for indoor radon below current guidelines 2Tough yet stiff deer antler is materials scientist's dream 2Insmed CEO Resigns Due to Health Concerns 12633 1Insmed CEO Resigns Due to Health Concerns 12633 2Insmed CEO Resigns Due to Health Concerns 12633 3Endologix Announces Live Web Cast of Presentation in SMH Capital Small Cap Spotlight on June 17 2009 at 4 3A15 p m ET 48957 1Endologix Announces Live Web Cast of Presentation in SMH Capital Small Cap Spotlight on June 17 2009 at 4 3A15 p m ET 48957 2SETO Holdings Inc Completes Agreement to Acquire Advanced Hearing Centers Inc and Has Disposed of All Existing Business 3B New Management has been 48953 1SETO Holdings Inc Completes Agreement to Acquire Advanced Hearing Centers Inc and Has Disposed of All Existing Business 3B New Management has been 48953 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |